Role of New Biomarkers in the Early Diagnosis of Gestational Diabetes: A Mini Review
- 1 January 2026
- journal article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 26 (3) , 211-220
Abstract
Gestational diabetes (GDM) has become a major public health problem in recent years and one of the most debated topics in women's health. GDM is associated with serious health consequences for both the mother and the child in the short and long term. The prevalence of GDM varies between 0.6% and 20% (depending on the detection method, gestational age, and the population studied). Genetic, nutritional, epigenetic, immunological, and hormonal components have been identified in its pathophysiology. Today, the importance of identifying a biomarker to detect GDM from the beginning of pregnancy in women at high risk of developing GDM is frequently emphasized. In recent years, adipokines and cytokines have been reported to play important roles in the metabolic changes underlying GDM. The purpose of this study was to reveal the potential and importance of the recently identified chemerin, omentin-1, resistin, visfatin, and asprosin peptides with different mechanisms of action in the pathogenesis of GDM.Keywords
This publication has 104 references indexed in Scilit:
- Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDMActa Diabetologica, 2019
- Serum levels of adipokines in gestational diabetes: a systematic reviewJournal of Endocrinological Investigation, 2018
- Maternal and neonatal omentin-1 levels in gestational diabetesArchives of Gynecology and Obstetrics, 2018
- Impact of risk factors for gestational diabetes (GDM) on pregnancy outcomes in women with GDMJournal of Endocrinological Investigation, 2017
- The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetesDiabetes/Metabolism Research and Reviews, 2017
- The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysisDiabetologia, 2011
- Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimesterJournal of Endocrinological Investigation, 2008
- Screening for biomarkers predictive of gestational diabetes mellitusActa Diabetologica, 2008
- Early onset of subclinical atherosclerosis in women with gestational diabetes mellitusUltrasound in Obstetrics & Gynecology, 2006
- Inflammatory markers in women with a recent history of gestational diabetes mellitusJournal of Endocrinological Investigation, 2005